ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,244,029 | -73.2% | 9,438,762 | +3.6% | 0.00% | – |
| Q2 2023 | $4,646,959 | -19.4% | 9,111,684 | -0.5% | 0.00% | – |
| Q1 2023 | $5,768,117 | -2.9% | 9,155,741 | +0.1% | 0.00% | – |
| Q4 2022 | $5,937,799 | -62.3% | 9,147,741 | -0.2% | 0.00% | – |
| Q3 2022 | $15,759,000 | +36.7% | 9,162,523 | -1.4% | 0.00% | – |
| Q2 2022 | $11,527,000 | +63.9% | 9,295,855 | -13.8% | 0.00% | – |
| Q1 2022 | $7,032,000 | -44.5% | 10,778,670 | -7.3% | 0.00% | – |
| Q4 2021 | $12,681,000 | -43.7% | 11,633,700 | -6.1% | 0.00% | -100.0% |
| Q3 2021 | $22,543,000 | -45.9% | 12,385,833 | -21.5% | 0.00% | 0.0% |
| Q2 2021 | $41,652,000 | -27.9% | 15,777,466 | -1.7% | 0.00% | -50.0% |
| Q1 2021 | $57,771,000 | +43.6% | 16,047,454 | +0.5% | 0.00% | +100.0% |
| Q4 2020 | $40,244,000 | +4.5% | 15,969,421 | +4.5% | 0.00% | 0.0% |
| Q3 2020 | $38,515,000 | -24.2% | 15,283,436 | -1.3% | 0.00% | -50.0% |
| Q2 2020 | $50,790,000 | +36.8% | 15,484,686 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $37,133,000 | -37.5% | 15,156,323 | +20.3% | 0.00% | 0.0% |
| Q4 2019 | $59,448,000 | +24.3% | 12,595,011 | +12.7% | 0.00% | 0.0% |
| Q3 2019 | $47,818,000 | -27.1% | 11,172,273 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $65,615,000 | +69.0% | 11,254,728 | +11.6% | 0.00% | 0.0% |
| Q1 2019 | $38,833,000 | +271.9% | 10,086,765 | +80.7% | 0.00% | – |
| Q4 2018 | $10,441,000 | -62.9% | 5,582,981 | -36.4% | 0.00% | -100.0% |
| Q3 2018 | $28,108,000 | +8.4% | 8,783,696 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $25,939,000 | -21.5% | 8,589,255 | +1.9% | 0.00% | 0.0% |
| Q1 2018 | $33,046,000 | -6.0% | 8,430,119 | -0.7% | 0.00% | -50.0% |
| Q4 2017 | $35,158,000 | -30.1% | 8,492,365 | +3.7% | 0.00% | 0.0% |
| Q3 2017 | $50,270,000 | +2.8% | 8,187,146 | +4.1% | 0.00% | 0.0% |
| Q2 2017 | $48,917,000 | +5.5% | 7,864,470 | +7.6% | 0.00% | 0.0% |
| Q1 2017 | $46,348,000 | +25.3% | 7,310,537 | +5.7% | 0.00% | 0.0% |
| Q4 2016 | $36,990,000 | -2.2% | 6,913,859 | +2.9% | 0.00% | 0.0% |
| Q3 2016 | $37,828,000 | +2.4% | 6,719,061 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $36,928,000 | -24.3% | 6,726,316 | +2.3% | 0.00% | -33.3% |
| Q1 2016 | $48,763,000 | -8.2% | 6,571,912 | +2.8% | 0.00% | -25.0% |
| Q4 2015 | $53,104,000 | +33.5% | 6,390,428 | +44.7% | 0.00% | +300.0% |
| Q3 2015 | $39,781,000 | -21.3% | 4,415,125 | +4.9% | 0.00% | -66.7% |
| Q2 2015 | $50,527,000 | +49.4% | 4,210,563 | +34.1% | 0.00% | +50.0% |
| Q1 2015 | $33,823,000 | +145.1% | 3,140,477 | +15.4% | 0.00% | +100.0% |
| Q4 2014 | $13,801,000 | +94.4% | 2,722,054 | +1.3% | 0.00% | 0.0% |
| Q3 2014 | $7,098,000 | -38.3% | 2,688,407 | -5.9% | 0.00% | 0.0% |
| Q2 2014 | $11,509,000 | -1.0% | 2,855,937 | +12.5% | 0.00% | 0.0% |
| Q1 2014 | $11,628,000 | +10.2% | 2,538,893 | +4.5% | 0.00% | 0.0% |
| Q4 2013 | $10,547,000 | +29.1% | 2,429,993 | +17.5% | 0.00% | 0.0% |
| Q3 2013 | $8,168,000 | +112.4% | 2,067,764 | +12.9% | 0.00% | – |
| Q2 2013 | $3,846,000 | – | 1,831,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |